Man Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.8M | Buy |
525,069
+11,848
| +2% | +$1.24M | 0.1% | 199 |
|
|
2025
Q1 | $59.9M | Buy |
513,221
+349,833
| +214% | +$40.8M | 0.15% | 130 |
|
|
2024
Q4 | $13.8M | Buy |
+163,388
| New | +$13.8M | 0.04% | 516 |
|
|
2023
Q1 | – | Sell |
-116,492
| Closed | -$8.99M | – | 2023 |
|
|
2022
Q4 | $8.99M | Buy |
+116,492
| New | +$8.99M | 0.03% | 615 |
|
|
2021
Q3 | – | Sell |
-7,994
| Closed | -$539K | – | 1815 |
|
|
2021
Q2 | $539K | Sell |
7,994
-33,907
| -81% | -$2.29M | ﹤0.01% | 1535 |
|
|
2021
Q1 | $2.37M | Buy |
41,901
+1,395
| +3% | +$79K | 0.01% | 1038 |
|
|
2020
Q4 | $3.3M | Sell |
40,506
-2,304
| -5% | -$188K | 0.01% | 997 |
|
|
2020
Q3 | $3.05M | Buy |
42,810
+28,383
| +197% | +$2.02M | 0.01% | 1039 |
|
|
2020
Q2 | $1.19M | Buy |
+14,427
| New | +$1.19M | 0.01% | 1222 |
|